Description

PSMA I&T is a potent PSMA (prostate-specific membrane antigen) inhibitor. PSMA I&T can be used for SPECT/CT imaging and radionuclide research of prostate cancer (PCa)[1].–20°C (Powder, sealed storage, away from moisture)-Applications-Cancer-programmed cell death-Formula-C63H92IN11O23-Citation–References-[1]Chatalic KL, et al. Towards Personalized Treatment of Prostate Cancer: PSMA I&T, a Promising Prostate-Specific Membrane Antigen-Targeted Theranostic Agent. Theranostics. 2016 Apr 12;6(6):849-61.-CASNumber-2192281-54-0-MolecularWeight-1498.37-Compound Purity-99.67-SMILES-IC(C=C1C[C@H](C(N[C@@H](C(N[C@@H](C(O)=O)CCCCNC(CCCCCCC(NCCCC[C@@H](C(O)=O)NC(N[C@H](C(O)=O)CCC(O)=O)=O)=O)=O)=O)CC2=CC=CC=C2)=O)NC(CCC(N3CCN(CCN(CCN(CC3)CC(O)=O)CC(O)=O)CC(O)=O)C(O)=O)=O)=C(C=C1)O-Research_Area-Cancer-Solubility-DMSO : 100 mg/mL (ultrasonic;warming;heat to 60°C)-Target-PSMA-Isoform–Pathway-Immunology/Inflammation-MCE Product type-ADC Related